Crosstalk between activated and inactivated c-Src in hepatocellular carcinoma
Related Experiment Video
Updated: May 31, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Mei-Lin Chen1, Chee-Yin Chai, Kun-Tu Yeh
1Department of Pathology, Changhua Christian Hospital, Taiwan.
Abstract:
C-Src activity is regulated by tyrosine phosphorylation at two distinct sites, Tyr416 and Tyr527, with opposite effects. However, the clinical roles of these sites in human cancers are not well defined. This study aims to determine whether the alterations and crosstalk of these two sites may contribute to hepatocellular carcinoma (HCC). Specimens from 85 patients who had undergone curative hepatectomy were collected for this study. The patterns of p-Tyr416-Src and p-Tyr527-Src, as well as the non-phosphorylated status for each site, were determined using immunohistochemistry and statistically correlated with clinicopathological characteristics and overall survival rate. The active state of c-Src, p-Tyr416-c-Src, was positively correlated with tumour grade (P=0.062) but inversely correlated with vascular invasion (P=0.071). Its non-phosphorylated status, non-p-Tyr416-c-Src, was positively correlated with tumour stage and grade (P= 0.041 and 0.020). The inactive state of c-Src, p-Tyr527-c-Src, was decreased in male patients but increased HCV-infected patients (P=0.044 and 0.033). The Kaplan-Meier survival curve further showed that increased p-Tyr416-c-Src and decreased non-p-Tyr527-c-Src expression were associated with a poor patient survival rate (P=0.004 and 0.025). Interestingly, the expression of non-p-Tyr416-c-Src was positively correlated with that of p-Tyr527-c-Src in the HCC lesions (P=0.040). In addition, the patients with concomitantly low p-Tyr416-c-Src and non-p-Tyr527-c-Src expression had a prolonged overall survival rate (P=0.030). A multivariable COX regression model showed that p-Tyr416-c-Src expression was an effective predictor for patient survival in HCC [OR =3.78, 95% CI =1.46-9.76; P=0.006]. Our results suggest that the active state of c-Src, p-Tyr416-c-Src, may serve as an independent prognostic marker of patient survival in HCC. Relative levels of other phosphorylated or non-phosphorylated c-Src kinases may also present different statuses during HCC development and require further investigation.
Insights
Active c-Src (p-Tyr416-c-Src) is a potential prognostic marker for hepatocellular carcinoma (HCC) survival. Its expression, along with non-phosphorylated c-Src (non-p-Tyr527-c-Src), offers insights into HCC patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- c-Src activity is regulated by tyrosine phosphorylation at Tyr416 and Tyr527 sites.
- The clinical significance of these phosphorylation sites in human cancers, particularly hepatocellular carcinoma (HCC), remains unclear.
Purpose of the Study:
- To investigate the role of c-Src phosphorylation at Tyr416 and Tyr527 in hepatocellular carcinoma (HCC).
- To determine if alterations and crosstalk between these sites contribute to HCC development and patient prognosis.
Main Methods:
- Immunohistochemistry was used to analyze the expression patterns of phosphorylated and non-phosphorylated c-Src at Tyr416 and Tyr527 in 85 HCC patient specimens.
- Statistical correlations were performed between these expression patterns and clinicopathological characteristics, including tumor grade, stage, vascular invasion, and patient survival rates.
Main Results:
- Active c-Src (p-Tyr416-c-Src) correlated positively with tumor grade and inversely with vascular invasion.
- Non-phosphorylated c-Src (non-p-Tyr416-c-Src) correlated with tumor stage and grade.
- Inactive c-Src (p-Tyr527-c-Src) levels differed between male and HCV-infected patients.
- Increased p-Tyr416-c-Src and decreased non-p-Tyr527-c-Src were associated with poor survival.
- Low p-Tyr416-c-Src and non-p-Tyr527-c-Src expression predicted prolonged survival.
- p-Tyr416-c-Src expression was an independent predictor of HCC patient survival.
Conclusions:
- Active c-Src (p-Tyr416-c-Src) may serve as an independent prognostic marker for HCC patient survival.
- The interplay between different c-Src phosphorylation states warrants further investigation in HCC development.
Related Concept Videos
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Ras Gene
Ras is a superfamily...
MAPK Signaling Cascades
Induced Pluripotent Stem Cells
Somatic cells are...
